Repository logo
  • English
  • CatalĆ 
  • ČeÅ”tina
  • Deutsch
  • EspaƱol
  • FranƧais
  • GĆ idhlig
  • Italiano
  • LatvieÅ”u
  • Magyar
  • Nederlands
  • Polski
  • PortuguĆŖs
  • PortuguĆŖs do Brasil
  • Suomi
  • Svenska
  • TürkƧe
  • Tiįŗæng Việt
  • ŅšŠ°Š·Š°Ņ›
  • বাংলা
  • ą¤¹ą¤æą¤‚ą¤¦ą„€
  • Ελληνικά
  • YŠŗŃ€Š°Ń—ĢŠ½ŃŃŒŠŗŠ°
  • Log In
    Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of NRU
  • English
  • CatalĆ 
  • ČeÅ”tina
  • Deutsch
  • EspaƱol
  • FranƧais
  • GĆ idhlig
  • Italiano
  • LatvieÅ”u
  • Magyar
  • Nederlands
  • Polski
  • PortuguĆŖs
  • PortuguĆŖs do Brasil
  • Suomi
  • Svenska
  • TürkƧe
  • Tiįŗæng Việt
  • ŅšŠ°Š·Š°Ņ›
  • বাংলা
  • ą¤¹ą¤æą¤‚ą¤¦ą„€
  • Ελληνικά
  • YŠŗŃ€Š°Ń—ĢŠ½ŃŃŒŠŗŠ°
  • Log In
    Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Alepere, Juliet"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease
    (New England Journal of Medicine, 2022) Beaton, Andrea; Okello, Emmy; Rwebembera, Joselyn; Alepere, Juliet; Lwabi, Peter; Nakitto, Miriam; Ndagire, Emma; Omara, Isaac O.; Karthikeyan, Ganesan; Steer, Andrew C.
    Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage. Whether secondary antibiotic prophylaxis is effective in preventing progression of latent rheumatic heart disease is unknown.

Research Dissemination Platform copyright Ā© 2002-2026 NRU

  • Cookie settings
  • Privacy policy
  • End User Agreement